Pfizer Cuts Medicaid Drug Prices in Deal with Trump Amid Tariff Threats
In a major agreement announced on 30 September 2025, pharmaceutical giant Pfizer has struck a deal with the Trump administration to lower the cost of prescription drugs sold to Medicaid, the U.S. government health programme for low-income Americans. Under the deal, Pfizer will match what is known as “most-favoured